Roberto Vendramin

Also affiliated with Cancer Research UK, London Cancer, Immunité et Cancer, CRUK Lung Cancer Centre of Excellence, University College London

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance”.

The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance

Nature Genetics(2023)10.1038/s41588-023-01592-8

N/A

1.9DataRank · unranked

88 citations

Philippe Gui, Manasi K. Mayekar, Emily K. Law, Oriol Pich, Chris Bailey +80 more

Prospective validation of ORACLE, a clonal expression biomarker associated with survival of patients with lung adenocarcinoma

Nature Cancer(2025)10.1038/s43018-024-00883-1

N/A

0.456DataRank · unranked

13 citations

Yun-Hsin Liu, Javier Herrero, Yin Wu, David A. Moore, Takahiro Karasaki +95 more

Targeted chemotherapy overcomes drug resistance in melanoma

Genes & Development(2020)10.1101/gad.333864.119

N/A

0DataRank · unranked

37 citations

Roberto Vendramin, Fan Liu, Omar López, M. Valencia-S., Helena G. Dos Santos +8 more

MHC Hammer reveals genetic and non-genetic HLA disruption in cancer evolution

Nature Genetics(2024)10.1038/s41588-024-01883-8

N/A

0DataRank · unranked

40 citations

Thomas P. Jones, Michelle Leung, Felipe Gálvez‐Cancino, Jiali Liu, Manuel Varas‐Godoy +87 more